Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Flash presentation: Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Valproates

by Sturkenboom, Miriam , Duran-Salinas, Carlos , Alsina, Ema , Gamba, Magdalena , Riera-Arnau, Judit , Bartolini, Claudia , Abtahi, Shahab , Klungel, Olaf , Holthuis, Emily , Martéin-Pérez, Mar , Pajouheshnia, Romin , Limoncella, Giorgio , Brown, Jeremy , Hallgreen, Christine Erikstrup

in Alternative medicine / Contraceptives / Optimization / Pregnancy / Teratogenicity / Trends

2022

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Flash presentation: Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Valproates

in Alternative medicine / Contraceptives / Optimization / Pregnancy / Teratogenicity / Trends

2022

Confirm

Do you wish to request the book?

Flash presentation: Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Valproates

in Alternative medicine / Contraceptives / Optimization / Pregnancy / Teratogenicity / Trends

2022

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Flash presentation: Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Valproates

Sturkenboom, Miriam,

Duran-Salinas, Carlos,

Alsina, Ema,

Gamba, Magdalena,

Riera-Arnau, Judit,

Bartolini, Claudia,

Abtahi, Shahab,

Klungel, Olaf,

Holthuis, Emily,

Martéin-Pérez, Mar,

Pajouheshnia, Romin,

Limoncella, Giorgio,

Brown, Jeremy,

Hallgreen, Christine Erikstrup

2022

Overview

Introduction: Due to the established teratogenic effects of valproates [1], the European risk minimisation measures (RMMs) for valproates were updated in March 2018 [2]. This included assessment of patients' potential to become pregnant, pregnancy testing, contraceptive use and annual review of ongoing treatment.

Share this book

Add to My Shelf

Publisher

Springer Nature B.V

Subject

/ Trends